Sonnet BioTherapeutics, Inc. (NASDAQ:SONN) | WebDisclosure

Basculer en Français

10596	Companies
224738	Keywords
153458	Articles
118882	Press releases

Headlines Articles Press releases Sonnet BioTherapeutics, Inc.

Home
Companies
Sonnet BioTherapeutics, Inc.

PRESS RELEASE

published on 02/29/2024 at 22:05, 2 years 3 months ago

Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability

Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
PRESS RELEASE

published on 02/14/2024 at 13:30, 2 years 4 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023

Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
PRESS RELEASE

published on 12/21/2023 at 14:00, 2 years 5 months ago

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
PRESS RELEASE

published on 12/14/2023 at 22:15, 2 years 6 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRESS RELEASE

published on 10/31/2023 at 12:30, 2 years 7 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
PRESS RELEASE

published on 10/25/2023 at 13:30, 2 years 7 months ago

Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
PRESS RELEASE

published on 10/17/2023 at 14:00, 2 years 8 months ago

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
PRESS RELEASE

published on 09/20/2023 at 13:30, 2 years 8 months ago

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

Accesswire

Published on 06/18/2026 at 15:50, 38 minutes ago

Pentagon I Capital Corp. and Prospectiva Resources Ltd. Announce Financing
Published on 06/18/2026 at 15:00, 1 hour 28 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 1 hour 58 minutes ago

Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026
Published on 06/18/2026 at 14:30, 1 hour 58 minutes ago

Rochon Family Executes Strategic Purchase of AIAI Holdings Shares
Published on 06/18/2026 at 14:25, 2 hours 3 minutes ago

Sparton Acquires Option to Past Producing Silver Property and Strengthens Board at AGM

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 16:10, 17 minutes ago

EQS-Adhoc: DOUGLAS AG: Updated Guidance for 2025/26
Published on 06/18/2026 at 16:10, 17 minutes ago

Orion Innovation Achieves AWS Migration Competency for Cloud Transformation
Published on 06/18/2026 at 16:05, 22 minutes ago

Rockwell Automation Introduces FactoryTalk ResilientEdge to Enable Autonomous, Scalable Manufacturing Operations
Published on 06/18/2026 at 16:05, 22 minutes ago

Cision Launches AI Coverage Analysis in CisionOne to Help PR Teams Move from Coverage to Action
Published on 06/18/2026 at 15:27, 1 hour ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc

Les Echos

Published on 06/18/2026 at 13:00, 3 hours 27 minutes ago

Edenred statement
Published on 06/18/2026 at 13:00, 3 hours 27 minutes ago

Communiqué Edenred
Published on 06/18/2026 at 09:06, 7 hours 21 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 09:06, 7 hours 21 minutes ago

Eiffage, membre de la co-entreprise NSORe, remporte le marché de la station de conversion du projet de raccordement au réseau offshore NSC2 en Allemagne
Published on 06/18/2026 at 08:30, 7 hours 58 minutes ago

OPmobility wins first awards with Chinese automaker Leapmotor outside of China

View all LES ECHOS COMFI WIRE